Citadel Advisors - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 37 filers reported holding THE ONCOLOGY INSTITUTE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$59,804
-86.1%
42,717
-29.3%
0.00%
Q1 2022$431,000
+11.7%
60,387
+52.6%
0.00%
Q4 2021$386,00039,5610.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Parian Global Management LP 183,828$930,0004.26%
Velan Capital Investment Management LP 600,000$3,036,0003.08%
Triatomic Management LP 365,679$1,850,0001.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,383,099$17,118,0000.35%
Redmile Group, LLC 1,736,116$8,785,0000.34%
Saba Capital Management, L.P. 367,292$1,858,0000.02%
FMR LLC 12,000,078$60,720,0000.01%
BANK OF AMERICA CORP /DE/ 6,251$31,0000.00%
WELLS FARGO & COMPANY/MN 470$2,0000.00%
NORTHERN TRUST CORP 143,921$729,0000.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders